{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:40:12Z","timestamp":1756665612125,"version":"3.44.0"},"reference-count":36,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08279"],"award-info":[{"award-number":["22K08279"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,11,30]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Idiopathic pleuroparenchymal fibroelastosis (iPPFE), a progressive fibrotic disease, is characterised by upper lobe\u2013dominant lung fibrosis involving the pleura and subpleural lung parenchyma. However, no prognostic markers have been established for this condition. Associations between blood leucocyte levels and mortality have been reported in patients with idiopathic pulmonary fibrosis; therefore, we hypothesised that peripheral leucocyte levels are associated with mortality risk in patients with iPPFE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study longitudinally assessed peripheral leucocyte counts at the time of diagnosis and 1 year after diagnosis in two cohorts of 127 patients with iPPFE (69 and 58 patients in Seirei and Hamamatsu cohorts, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A comprehensive assessment of peripheral leucocytes revealed that the neutrophil\u2013lymphocyte ratio (NLR) was associated with mortality in patients with iPPFE after adjusting for age, sex and forced vital capacity in multivariate analyses (adjusted HR, 1.131; 95% CI, 1.032 to 1.227). When the patients were classified based on the median NLR, those with a high NLR had shorter survival than those with a low NLR (median, 32.2 vs 79.8 months; HR, 2.270; 95% CI, 1.416 to 3.696). Interestingly, the results of the NLR classification by median were longitudinally preserved in &gt;70% of patients, and patients with consistently high NLR were at a higher risk of mortality than others (median, 24.8 vs 79.6 months; HR, 3.079; 95% CI, 1.878 to 5.031). Compared with the gender\u2013age\u2013physiology model, a composite model comprising age, sex and NLR could successfully stratify patients with iPPFE into three groups according to mortality risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The assessment of peripheral leucocyte counts is easy and might be useful in evaluating disease severity and mortality risk in patients with iPPFE. Our study suggests the importance of focusing on peripheral leucocyte levels in daily practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-001763","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:50:44Z","timestamp":1702335044000},"page":"e001763","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Neutrophil\u2013lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-9791","authenticated-orcid":false,"given":"Yuzo","family":"Suzuki","sequence":"first","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Seirei Hamamatsu Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Seirei Hamamatsu Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Yokomura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Imokawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Iwata City Hospital, Iwata, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0455-4070","authenticated-orcid":false,"given":"Masato","family":"Karayama","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"2025083111201272000_10.1.e001763.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2025083111201272000_10.1.e001763.2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1513\/AnnalsATS.201902-181CME","article-title":"Pleuroparenchymal fibroelastosis. A review of clinical, radiological, and pathological characteristics","volume":"16","author":"Chua","year":"2019","journal-title":"Annals ATS"},{"key":"2025083111201272000_10.1.e001763.3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02243-2018","article-title":"Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion","volume":"53","author":"Fujisawa","year":"2019","journal-title":"Eur Respir J"},{"key":"2025083111201272000_10.1.e001763.4","doi-asserted-by":"crossref","first-page":"106078","DOI":"10.1016\/j.rmed.2020.106078","article-title":"Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis","volume":"171","author":"Suzuki","year":"2020","journal-title":"Respir Med"},{"key":"2025083111201272000_10.1.e001763.5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jamaoncol.2019.1747","article-title":"Prognostic value of the lung immune prognostic index for patients treated for metastatic non-small cell lung cancer","volume":"5","author":"Kazandjian","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025083111201272000_10.1.e001763.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623430","article-title":"Multi-modal characterization of monocytes in idiopathic pulmonary fibrosis reveals a primed type I interferon immune phenotype","volume":"12","author":"Fraser","year":"2021","journal-title":"Front Immunol"},{"key":"2025083111201272000_10.1.e001763.7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","article-title":"Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study","volume":"7","author":"Scott","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025083111201272000_10.1.e001763.8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01855-2019","article-title":"Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF Registry","volume":"55","author":"Teoh","year":"2020","journal-title":"Eur Respir J"},{"key":"2025083111201272000_10.1.e001763.9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1164\/rccm.202003-0669OC","article-title":"Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis","volume":"204","author":"Kreuter","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083111201272000_10.1.e001763.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001202","article-title":"Neutrophil lymphocyte ratio as an indicator for disease progression in idiopathic pulmonary fibrosis","volume":"9","author":"Achaiah","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"2025083111201272000_10.1.e001763.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101758","article-title":"Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis","volume":"55","author":"Mikolasch","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025083111201272000_10.1.e001763.12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00637-2022","article-title":"Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume","volume":"60","author":"Fukada","year":"2022","journal-title":"Eur Respir J"},{"key":"2025083111201272000_10.1.e001763.13","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00749-2022","article-title":"Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis","volume":"9","author":"Suzuki","year":"2023","journal-title":"ERJ Open Res"},{"key":"2025083111201272000_10.1.e001763.14","doi-asserted-by":"crossref","unstructured":"Suzuki Y , Yoshimura K , Enomoto Y , et al . Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis. Sci Rep 2018;8. doi:10.1038\/s41598-018-32478-z","DOI":"10.1038\/s41598-018-32478-z"},{"key":"2025083111201272000_10.1.e001763.15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.11.003","article-title":"Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study","volume":"133","author":"Enomoto","year":"2017","journal-title":"Respir Med"},{"key":"2025083111201272000_10.1.e001763.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00165111"},{"key":"2025083111201272000_10.1.e001763.17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13665-017-0160-5","article-title":"Idiopathic pleuroparenchymal fibroelastosis","volume":"6","author":"Bonifazi","year":"2017","journal-title":"Curr Pulmonol Rep"},{"key":"2025083111201272000_10.1.e001763.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2020.100298","article-title":"Pleuroparenchymal fibroelastosis-like lesions in patients with interstitial pneumonia diagnosed by multidisciplinary discussion with surgical lung biopsy","volume":"7","author":"Sumikawa","year":"2020","journal-title":"Eur J Radiol Open"},{"key":"2025083111201272000_10.1.e001763.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01892-9","article-title":"Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial Pneumonias","volume":"22","author":"Fujisawa","year":"2021","journal-title":"Respir Res"},{"key":"2025083111201272000_10.1.e001763.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2025083111201272000_10.1.e001763.21","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/82.4.777"},{"key":"2025083111201272000_10.1.e001763.22","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00006713"},{"key":"2025083111201272000_10.1.e001763.23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00004"},{"key":"2025083111201272000_10.1.e001763.24","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"2025083111201272000_10.1.e001763.25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1474"},{"key":"2025083111201272000_10.1.e001763.26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/resp.14523","article-title":"Geriatric nutritional risk index is a Predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis","volume":"28","author":"Mochizuka","year":"2023","journal-title":"Respirology"},{"key":"2025083111201272000_10.1.e001763.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807508"},{"key":"2025083111201272000_10.1.e001763.28","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"2025083111201272000_10.1.e001763.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1109OC"},{"key":"2025083111201272000_10.1.e001763.30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203476"},{"key":"2025083111201272000_10.1.e001763.31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2014.00056","article-title":"Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis","volume":"1","author":"Moore","year":"2014","journal-title":"Front Med"},{"key":"2025083111201272000_10.1.e001763.32","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3HI1014-493R"},{"key":"2025083111201272000_10.1.e001763.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0653-3","article-title":"Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis","volume":"18","author":"Hou","year":"2017","journal-title":"Respir Res"},{"key":"2025083111201272000_10.1.e001763.34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162152"},{"key":"2025083111201272000_10.1.e001763.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1948"},{"key":"2025083111201272000_10.1.e001763.36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S2213-2600(17)30349-1","article-title":"Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study","volume":"5","author":"Herazo-Maya","year":"2017","journal-title":"Lancet Respir Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-001763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:20:24Z","timestamp":1756664424000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,11]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjresp-2023-001763"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-001763","relation":{},"ISSN":["2052-4439"],"issn-type":[{"type":"electronic","value":"2052-4439"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}